News Releases

ITUS Corporation Licenses CAR-T Technology from The Wistar Institute

November 14, 2017

ITUS Corporation Pays Off Secured Debenture

October 27, 2017

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 3, 2017

ITUS Corporation Completes At-the-Market Offering

October 2, 2017

ITUS Presentation to Annual Meeting of Stockholders

September 26, 2017

ITUS Corporation to Present at the 2017 Disruptive Growth Company Showcase NYC Presented by SeeThruEquity and RHK Capital

September 25, 2017

ITUS Provides Update on Cancer Detection Technology and New CAR-T Initiative for Ovarian Cancer

September 21, 2017

ITUS Corporation Announces Issuance of Patent on Cancer Detection Technology

September 18, 2017

The Wistar Institute and ITUS Corporation Renew Collaborative Research Agreement

August 7, 2017

Lew Titterton re-joins ITUS Corporation's Board of Directors

July 18, 2017

Latest News & Events

Jan 6, 2020

Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference

Read More...

Dec 23, 2019

Anixa Biosciences to Present at Biotech Showcase 2020

Read More...

Dec 16, 2019

Anixa Biosciences Announces Commercial Launch of Cchek™ Prostate Cancer Confirmatory Test

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.